FAS and prostate cancer: In conclusion, the present study has identified a novel mechanism of synergistic cell death with sildenafil and DOX in prostate cancer cells which involves increased surface localization of CD95, with concomitant inactivation of NF-κB and suppression of FLIP and FAP-1 expression (Figure 9).